Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2019

01-04-2019 | Images

Marked Thrombocytosis and Megakaryocytic Dysplasia in NPM1 Mutated De-Novo Acute Myeloid Leukemia

Authors: Aastha Gupta, Naveen Gupta, Prasad Dange, Haraprasad Pati

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2019

Login to get access

Excerpt

44 year old female presented with gum bleeding since 1 week. No organomegaly was seen. The hemogram revealed hemoglobin—100 g/L, total leucocyte count—4.2 × 109/L and platelet—1500 × 109/L. Previous counts, done 2 months back were normal. Peripheral smear showed marked thrombocytosis and 41% blasts with Auer rod (Fig. 1). Marrow showed similar blasts (47%). Megakaryocytes were adequate with bizarre morphology including large and hyper lobulated forms with some showing separated nuclei (Fig. 2). Maturing myeloid and erythroid components were seen without significant dysplasia. On immunophenotyping, the blasts were positive for MPO, CD34 (weak), CD117 and were negative for HLA-DR. Cytogenetics was normal (46, XX). Molecular genetic analysis showed mutation of NPM1 (by RT-PCR) with no FLT3-ITD (by RT-PCR) mutation. Subtyping of the NPM-1 mutation could not be done due to availability issue. Underlying myeloproliferative neoplasm(MPN) was excluded with negative result for BCR-ABL1 (by multiplex PCR), JAK2 (by ARMS-PCR), calreticulin and MPL mutation. Final diagnosis of acute myeloid leukemia (AML) with mutated NPM1 was made.
Literature
1.
go back to reference Chen Y, Pourabdollah M, Chang H (2017) Acute myeloid leukemia with mutated NPM1 demonstrating multilineage dysplasia and marked thrombocytosis. Br J Haematol 178(3):350CrossRefPubMed Chen Y, Pourabdollah M, Chang H (2017) Acute myeloid leukemia with mutated NPM1 demonstrating multilineage dysplasia and marked thrombocytosis. Br J Haematol 178(3):350CrossRefPubMed
2.
go back to reference Wang M, He N, Tian T, Liu L, Yu S, Ma D (2014) Mutation analysis of JAK2V617F, FLT3-ITD, NPM1, and DNMT3A in Chinese patients with myeloproliferative neoplasms. Biomed Res Int 2014:485645PubMedCentralPubMed Wang M, He N, Tian T, Liu L, Yu S, Ma D (2014) Mutation analysis of JAK2V617F, FLT3-ITD, NPM1, and DNMT3A in Chinese patients with myeloproliferative neoplasms. Biomed Res Int 2014:485645PubMedCentralPubMed
Metadata
Title
Marked Thrombocytosis and Megakaryocytic Dysplasia in NPM1 Mutated De-Novo Acute Myeloid Leukemia
Authors
Aastha Gupta
Naveen Gupta
Prasad Dange
Haraprasad Pati
Publication date
01-04-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-1047-5

Other articles of this Issue 2/2019

Indian Journal of Hematology and Blood Transfusion 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine